Table 2.
Description of study population by type of surgery according to age, education, social class, marital status, tumor stage, histology, adjuvant therapy
| Characteristic | Mastectomy (n = 89) | Breast-conserving (n = 226) | P value | ||
|---|---|---|---|---|---|
| Age | |||||
| 18–49 | 12 | 13% | 75 | 33% | <0.0001 |
| 50–59 | 22 | 25% | 57 | 25% | |
| 60–69 | 26 | 29% | 61 | 27% | |
| 70+ | 29 | 33% | 33 | 15% | |
| Education (years) | |||||
| 9 | 70 | 79% | 166 | 73% | 0.49a |
| 10 | 10 | 11% | 38 | 17% | |
| 12+ | 8 | 9% | 22 | 10% | |
| Employment status | |||||
| Active job | 17 | 19% | 81 | 36% | 0.44a |
| Unemployed | 5 | 6% | 10 | 4% | |
| Housewife | 48 | 54% | 98 | 43% | |
| Retired | 17 | 19% | 37 | 16% | |
| Marital status | |||||
| With spouse | 46 | 52% | 149 | 66% | 0.35a |
| Without spouse | 43 | 48% | 77 | 34% | |
| Number of concurrent chronic conditionsb | |||||
| 0 | 18 | 20% | 41 | 18% | 0.24a |
| 1 | 20 | 23% | 72 | 32% | |
| 2+ | 51 | 57% | 113 | 50% | |
| UICC stage | |||||
| I | 29 | 33% | 87 | 39% | 0.04a |
| IIA | 28 | 32% | 89 | 39% | |
| IIB | 32 | 36% | 50 | 22% | |
| Grading | |||||
| GI/GII | 53 | 60% | 127 | 56% | 0.94a |
| GIII/GIV | 35 | 40% | 97 | 43% | |
| Histology | |||||
| Lobular | 20 | 23% | 21 | 9% | 0.01a |
| Ductal | 63 | 71% | 182 | 81% | |
| Other | 6 | 7% | 23 | 10% | |
| Receptors | |||||
| Oestrogen | 64 | 72% | 157 | 69% | 0.95a |
| Progesteron | 64 | 72% | 140 | 62% | 0.15a |
| Adjuvant Therapy | |||||
| Chemotherapy | 31 | 35% | 106 | 47% | 0.87a |
| Radiation | 29 | 33% | 195 | 86% | <0.0001a |
| Hormonal | 63 | 71% | 141 | 62% | 0.44a |
aadjusted for age
bMyocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, musculoskeletal disorders, arthrosis, connective tissue disease, ulcer disease, liver disease, diabetes, stroke, renal disease, other malign tumor, AIDS, visual and hearing impairment